SRAM
RDY icon

Stone Ridge Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Stone Ridge Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-84,115
Closed -$892K – 375
2020
Q2 		$892K Hold
84,115
– – 0.14% 134
2020
Q1 		$678K Buy
84,115
+7,500
+10% +$62.5K 0.07% 309
2019
Q4 		$622K Buy
76,615
+2,500
+3% +$19.7K 0.04% 563
2019
Q3 		$562K Buy
74,115
+12,550
+20% +$93.3K 0.03% 642
2019
Q2 		$461K Buy
61,565
+30,500
+98% +$240K 0.03% 754
2019
Q1 		$252K Buy
+31,065
New +$236K 0.01% 965

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Stone Ridge Asset Management's RDY Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2020, closing a stake of 84,115 shares — an estimated $892K sold.

Stone Ridge Asset Management first reported a position in RDY in Q1 2019 and held it in 6 quarters. The position peaked at $892K in Q2 2020. 186 funds tracked by Wall St. Rank hold RDY as of Q3 2020.

  • Stone Ridge Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2020 after selling out during the quarter.
  • Stone Ridge Asset Management sold 84,115 Dr. Reddy's Laboratories shares in Q3 2020, an estimated $892K.
  • Stone Ridge Asset Management first reported a position in Dr. Reddy's Laboratories in Q1 2019 and held it in 6 quarters.
  • Stone Ridge Asset Management's Dr. Reddy's Laboratories position peaked at $892K in Q2 2020.
  • 186 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.